Table 1 The clinicopathological characteristics of 80 patients with LUAD.

From: Prognostic signature based on mitochondria quality control proteins for the prediction of lung adenocarcinoma patients survival

Characteristic

N = 80a

Follow-up time (months)

56 (20, 94)

Survival status

Alive

30 (38%)

Dead

50 (62%)

Age

 ≤65

50 (62%)

 >65

30 (38%)

Gender

 Female

29 (36%)

 Male

51 (64%)

T

 1–2

54 (68%)

 3–4

26 (32%)

N

 0

47 (59%)

 1–2

33 (41%)

M

 0

77 (96.2%)

 1

3 (3.8%)

Stage

 1–2

50 (62%)

 3–4

30 (38%)

Grade

 1–2

45 (56%)

Mixed

11 (14%)

 3–4

24 (30%)

Multiple primary malignant tumors

 Absence

74 (92.5%)

 Presence

6 (7.5%)

  1. aMedian (IQR); n (%).